Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019, to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019.
The above information is a part of company’s filings submitted to BSE.